Issued: March 27, 2014
Contact: Linda Miller

OMAHA, Neb. – Draft minimum standards for clinical and laboratory practice in regenerative medicine and related cellular therapies will be published next month by the Foundation for the Accreditation of Cellular Therapy (FACT).
Publication of the proposed standards is an important step toward voluntary accreditation, similar to FACT’s accreditation programs for hematopoietic cellular therapy and umbilical cord blood banking.
The draft standards will encompass cell collection, laboratory processing and patient care and are based on FACT’s 18 years of experience in cellular therapy standards and accreditation. Health professionals, industry representatives and the general public will be encouraged to submit comments about the proposed standards for 90 days after they are published on April 30. Read full release



Ask a Peer
FACT Consulting

Accreditation Success Story

The Héma-Québec Public Cord Blood Bank (CBB) was created in 2004 to meet the needs of Quebecers and to contribute to the international effort towards a high-quality global inventory of cord blood units. Read more